247 related articles for article (PubMed ID: 20822370)
1. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity.
Jun EA; Lim KM; Kim K; Bae ON; Noh JY; Chung KH; Chung JH
Nanotoxicology; 2011 Jun; 5(2):157-67. PubMed ID: 20822370
[TBL] [Abstract][Full Text] [Related]
2. Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets.
Bae ON; Lim KM; Noh JY; Chung SM; Kim H; Lee CR; Park JD; Chung JH
Chem Res Toxicol; 2007 Dec; 20(12):1760-8. PubMed ID: 17915961
[TBL] [Abstract][Full Text] [Related]
3. Trivalent methylated arsenical-induced phosphatidylserine exposure and apoptosis in platelets may lead to increased thrombus formation.
Bae ON; Lim KM; Noh JY; Chung SM; Kim SH; Chung JH
Toxicol Appl Pharmacol; 2009 Sep; 239(2):144-53. PubMed ID: 19167414
[TBL] [Abstract][Full Text] [Related]
4. Salsolinol, an endogenous neurotoxin, enhances platelet aggregation and thrombus formation.
Bae ON; Kim YD; Lim KM; Noh JY; Chung SM; Kim K; Hong S; Shin S; Yoon JH; Chung JH
Thromb Haemost; 2008 Jul; 100(1):52-9. PubMed ID: 18612538
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-induced platelet procoagulant activities: an important clue for chemotherapy-associated thrombosis.
Kim SH; Lim KM; Noh JY; Kim K; Kang S; Chang YK; Shin S; Chung JH
Toxicol Sci; 2011 Nov; 124(1):215-24. PubMed ID: 21865289
[TBL] [Abstract][Full Text] [Related]
6. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity.
Kim JE; Han M; Hanl KS; Kim HK
Thromb Res; 2011 May; 127(5):435-42. PubMed ID: 21296386
[TBL] [Abstract][Full Text] [Related]
8. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic mechanisms enhance platelet-mediated thrombogenicity.
Galan AM; Lopez-Vilchez I; Diaz-Ricart M; Navalon F; Gomez E; Gasto C; Escolar G
Thromb Haemost; 2009 Sep; 102(3):511-9. PubMed ID: 19718472
[TBL] [Abstract][Full Text] [Related]
10. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.
Kuijpers MJ; Munnix IC; Cosemans JM; Vlijmen BV; Reutelingsperger CP; Egbrink MO; Heemskerk JW
Microcirculation; 2008 May; 15(4):269-82. PubMed ID: 18464157
[TBL] [Abstract][Full Text] [Related]
11. Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation.
Bihari P; Holzer M; Praetner M; Fent J; Lerchenberger M; Reichel CA; Rehberg M; Lakatos S; Krombach F
Toxicology; 2010 Mar; 269(2-3):148-54. PubMed ID: 19698757
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
[TBL] [Abstract][Full Text] [Related]
13. New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation.
Xiong J; Bai L; Fang W; Fu J; Fang W; Cen J; Kong Y; Li Y
Eur J Pharm Sci; 2012 Apr; 45(5):552-8. PubMed ID: 22285483
[TBL] [Abstract][Full Text] [Related]
14. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
15. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
[TBL] [Abstract][Full Text] [Related]
16. Lead-induced procoagulant activation of erythrocytes through phosphatidylserine exposure may lead to thrombotic diseases.
Shin JH; Lim KM; Noh JY; Bae ON; Chung SM; Lee MY; Chung JH
Chem Res Toxicol; 2007 Jan; 20(1):38-43. PubMed ID: 17226925
[TBL] [Abstract][Full Text] [Related]
17. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine enhances platelet procoagulant activity.
Tomasiak M; Rusak T; Gacko M; Stelmach H
Nephrol Dial Transplant; 2007 Jun; 22(6):1750-6. PubMed ID: 17308321
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH
J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266
[TBL] [Abstract][Full Text] [Related]
20. Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.
Galbusera M; Buelli S; Gastoldi S; Macconi D; Angioletti S; Testa C; Remuzzi G; Morigi M
Xenotransplantation; 2005 Mar; 12(2):110-20. PubMed ID: 15693841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
